VW
NVS icon

Vantage Wealth’s Novartis NVS Stock Holding History

Vantage Wealth’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-119,820
Closed -$10.3M – 32
2019
Q1 		$10.3M Sell
119,820
-307
-0.3% -$24.6K 4.59% 3
2018
Q4 		$9.24M Buy
120,127
+128
+0.1% +$9.96K 4.77% 4
2018
Q3 		$9.26M Buy
119,999
+723
+0.6% +$53.4K 4% 11
2018
Q2 		$8.07M Buy
119,276
+628
+0.5% +$43.3K 3.88% 15
2018
Q1 		$8.6M Buy
118,648
+129
+0.1% +$9.82K 4.37% 8
2017
Q4 		$9.12M Hold
118,519
– – 4.83% 3
2017
Q3 		$9.12M Sell
118,519
-352
-0.3% -$26.6K 4.83% 3
2017
Q2 		$8.89M Sell
118,871
-2,466
-2% -$175K 4.74% 3
2017
Q1 		$8.07M Sell
121,337
-6,707
-5% -$447K 4.41% 10
2016
Q4 		$8.36M Sell
128,044
-129
-0.1% -$8.37K 4.59% 8
2016
Q3 		$9.07M Buy
128,173
+2,186
+2% +$159K 5.17% 6
2016
Q2 		$9.31M Sell
125,987
-1,967
-2% -$136K 5.93% 2
2016
Q1 		$8.31M Buy
127,954
+16,768
+15% +$1.14M 5.27% 4
2015
Q4 		$8.57M Buy
111,186
+23,984
+28% +$1.91M 4.93% 2
2015
Q3 		$7.18M Buy
87,202
+3,080
+4% +$274K 4.38% 7
2015
Q2 		$7.41M Buy
84,122
+166
+0.2% +$15.2K 4.3% 4
2015
Q1 		$7.42M Buy
83,956
+447
+0.5% +$39.6K 4.3% 4
2014
Q4 		$6.93M Buy
83,509
+1,367
+2% +$113K 4.06% 7
2014
Q3 		$6.93M Buy
82,142
+1,060
+1% +$85.8K 4.44% 6
2014
Q2 		$6.28M Sell
81,082
-12,611
-13% -$992K 4.17% 9
2014
Q1 		$7.14M Buy
93,693
+224
+0.2% +$16.3K 4.56% 4
2013
Q4 		$6.73M Sell
93,469
-1,278
-1% -$88.8K 4.35% 2
2013
Q3 		$6.51M Sell
94,747
-837
-0.9% -$55.4K 5.13% 1
2013
Q2 		$6.06M Buy
+95,584
New +$6.22M 4.81% 3

Other funds holding NVS

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Vantage Wealth's NVS Position: Q2 2019 in Review

Vantage Wealth sold out of Novartis (NVS) in Q2 2019, closing a stake of 119,820 shares — an estimated $10.3M sold.

Vantage Wealth first reported a position in NVS in Q2 2013 and held it in 24 quarters. The position peaked at $10.3M in Q1 2019. 1,094 funds tracked by Wall St. Rank hold NVS as of Q2 2019.

  • Vantage Wealth reported no remaining Novartis position as of Q2 2019 after selling out during the quarter.
  • Vantage Wealth sold 119,820 Novartis shares in Q2 2019, an estimated $10.3M.
  • Vantage Wealth first reported a position in Novartis in Q2 2013 and held it in 24 quarters.
  • Vantage Wealth's Novartis position peaked at $10.3M in Q1 2019.
  • 1,094 funds tracked by Wall St. Rank held Novartis as of Q2 2019.

Based on Vantage Wealth's 13F filing for Q2 2019, filed 13 Aug 2019.